Experience & Background
Christopher oversees Advisory Board research geared towards executives spanning the health care industry, and is responsible for shaping the company’s point of view on industry developments. He began his career as a health care financial analyst but has built wide-ranging expertise about the entire industry by leading countless studies on health system strategy, partnership and capital strategy, revenue cycle and supply chain operations during his 15+ years with the company. Christopher is regularly cited by the media and has been quoted by The New York Times and Washington Post. His work has also been published by Harvard Business Review.
Prior to joining Advisory Board, Christopher was editor of Editor of The Healthcare Investment Letter, a journalist for Louis Rukeyser’s investment advisories, and a biomedical researcher at the National Institutes of Health.
Education and Training
Christopher earned a BA from the University of Pennsylvania and received his MBA from the Robert H. Smith School of Business at the University of Maryland.
Areas of expertise
Strategy, Planning and Growth; Strategic and Business Planning; Finance; Health policy; Physician Alignment; Revenue Cycle; Cost Control, Covid-19
What you need to know about Christopher
Christopher has an extensive collection of Depeche Mode albums and merchandise that can only be described as obsessive.